Biomotion Sciences Ordinary Shares Cash Flow-to-Debt Ratio
Biomotion Sciences Ordinary Shares cash flow-to-debt ratio. Biomotion Sciences Ordinary Shares (SLXN) has a Cash Flow-to-Debt Ratio of -0.70x as of June 2026, meaning its operating cash flow of $-2.92 Million could theoretically repay -1% of its total liabilities ($4.20 Million) in one year. Check cash flow quality index of Biomotion Sciences Ordinary Shares to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Biomotion Sciences Ordinary Shares (2020–2025)
Cash flow-to-debt ratio of Biomotion Sciences Ordinary Shares from 2020 to 2025. Historical debt coverage capacity for Biomotion Sciences Ordinary Shares across 6 annual periods. Check total reinvestment intensity of Biomotion Sciences Ordinary Shares to assess the company's total reinvestment commitment from operating cash flow.
Biomotion Sciences Ordinary Shares Cash Flow-to-Debt Ratio by Year (2020–2025)
Biomotion Sciences Ordinary Shares cash flow-to-debt ratio by year from 2020 to 2025. Year-by-year debt coverage analysis for Biomotion Sciences Ordinary Shares. For the full cash flow conversion analysis, see SLXN cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.35x | $-10.82 Million | $4.61 Million | ▼ -91.4% |
| 2024 | -1.23x | $-8.40 Million | $6.85 Million | ▼ -368.4% |
| 2023 | -0.26x | $-4.53 Million | $17.31 Million | ▼ -28.7% |
| 2022 | -0.20x | $-3.33 Million | $16.41 Million | ▲ +92.7% |
| 2021 | -2.77x | $-1.41 Million | $508.92K | ▼ -1003.8% |
| 2020 | -0.25x | $-75.00K | $299.39K | — |